- Home
- MRSN
as of 12-26-2025 4:00pm EST
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | 138.8M | IPO Year: | 2017 |
| Target Price: | $30.38 | AVG Volume (30 days): | 52.9K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -14.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.21 - $40.88 | Next Earning Date: | 11-14-2025 |
| Revenue: | $33,180,000 | Revenue Growth: | -4.76% |
| Revenue Growth (this year): | -41.32% | Revenue Growth (next year): | -12.07% |
AI-Powered MRSN Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Mersana Therapeutics Inc. (MRSN)
SVP, Chief Development Officer
Avg Cost/Share
$9.90
Shares
77
Total Value
$762.30
Owned After
2,922
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Bala Mohan | MRSN | SVP, Chief Development Officer | Oct 27, 2025 | Sell | $9.90 | 77 | $762.30 | 2,922 |
Compare MRSN vs Leading Stocks
See how MRSN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MRSN Mersana Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.